These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28159516)

  • 21. Triptorelin Tethered Multifunctional PAMAM-Histidine-PEG Nanoconstructs Enable Specific Targeting and Efficient Gene Silencing in LHRH Overexpressing Cancer Cells.
    Tambe P; Kumar P; Karpe YA; Paknikar KM; Gajbhiye V
    ACS Appl Mater Interfaces; 2017 Oct; 9(41):35562-35573. PubMed ID: 28949503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy.
    Son S; Shin S; Rao NV; Um W; Jeon J; Ko H; Deepagan VG; Kwon S; Lee JY; Park JH
    Int J Biol Macromol; 2018 Apr; 110():406-415. PubMed ID: 29055700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.
    Gujrati M; Vaidya AM; Mack M; Snyder D; Malamas A; Lu ZR
    Adv Healthc Mater; 2016 Nov; 5(22):2882-2895. PubMed ID: 27723260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
    Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
    J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging.
    Chen G; Wang L; Cordie T; Vokoun C; Eliceiri KW; Gong S
    Biomaterials; 2015 Apr; 47():41-50. PubMed ID: 25682159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
    Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
    J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
    Liu CW; Lin WJ
    J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
    Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
    Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy.
    Li H; Yang X; Gao F; Qian C; Li C; Oupicky D; Sun M
    J Control Release; 2018 Dec; 292():78-90. PubMed ID: 29499219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
    Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
    J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect.
    Yang X; Fan B; Gao W; Li L; Li T; Sun J; Peng X; Li X; Wang Z; Wang B; Zhang R; Xie J
    Int J Nanomedicine; 2018; 13():4333-4344. PubMed ID: 30087564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
    Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
    Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide.
    Choi SW; Lee SH; Mok H; Park TG
    Biotechnol Prog; 2010; 26(1):57-63. PubMed ID: 19918765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
    Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
    Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bridge to silencing: Co-assembling anionic nanoparticles of siRNA and hyaluronan sulfate via calcium ion bridges.
    Forti E; Kryukov O; Elovic E; Goldshtein M; Korin E; Margolis G; Felder S; Ruvinov E; Cohen S
    J Control Release; 2016 Jun; 232():215-27. PubMed ID: 27117458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.